Experience with oseltamivir for infants younger than 1 year old in Japan.
Okamoto
Shigeru
S
Kamiya
Ichiro
I
Kishida
Kenji
K
Shimakawa
Tetsuro
T
Fukui
Tsuguya
T
Morimoto
Takeshi
T
D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007251:Influenza, Human / Q000150:complications / Q000188:drug therapy* / Q000401:mortality*; D020258:Neurotoxicity Syndromes / Q000453:epidemiology* / Q000401:mortality; D053139:Oseltamivir
D000081:Acetamides; D000998:Antiviral Agents; D053139:Oseltamivir